SEARCH

SEARCH BY CITATION

References

  • 1
    Koch C, Høiby N. Pathogenesis of cystic fibrosis. Lancet 1993; 341: 10659.
  • 2
    Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin Microbiol Rev 2002; 15: 194222.
  • 3
    Cryz SJ Jr, Fuerer E, Cross AS et al. Safety and immunogenicity of a Pseudomonas aeruginosa O-polysaccharide toxin A conjugate vaccine in humans. J Clin Invest 1987; 80: 516.
  • 4
    Cryz SJ Jr, Sadoff JC, Ohman D et al. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. J Lab Clin Med 1988; 111: 7017.
  • 5
    Cryz SJ Jr, Wedgewood J, Lang AB et al. Immunization of noncolonized cystic fibrosis patients against Pseudomonas aeruginosa. J Infect Dis 1994; 169: 115962.
  • 6
    Cryz SJ Jr, Lang A, Rudeberg A et al. Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine. Behring Inst Mitt 1997; 98: 3459.
  • 7
    Schaad UB, Lang AB, Wedgwood J et al. Safety and immunogenicity of Pseudomonas aeruginosa polyvalent conjugate A vaccine in cystic fibrosis. Lancet 1991; 338: 12367.
  • 8
    Lang AB, Schaad UB, Ruedeberg A et al. Effect of high-affinity anti-Pseudomonas aeruginosa lipopolysaccharide antibodies induced by immunization on the rate of Pseudomonas aeruginosa infection in patients with cystic fibrosis. J Pediatr 1995; 127: 7117.
  • 9
    Lang AB, Rüdeberg A, Schöni MH et al. Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection. Pediatr Infect Dis J 2004; 23: 50410.
  • 10
    Johansen HK, Hougen HP, Cryz SJ Jr et al. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia in rats. Am J Respir Crit Care Med 1995; 152: 133746.
  • 11
    Moser C, Johansen HK, Song Z et al. Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice. APMIS 1997; 105: 83842.
  • 12
    Moser C, Hougen HP, Song Z et al. Early immune response in susceptible and resistant mice strains with chronic Pseudomonas aeruginosa lung infection determines the type of T-helper cell response. APMIS 1999; 107: 1093100.
  • 13
    Moser C, Kjaergaard S, Pressler T et al. The immune response to chronic Pseudomonas aeruginosa lung infection in cycstic fibrosis patients is predominantly of the Th2 type. APMIS 2000; 108: 32935.
  • 14
    Kumoboj KK, Kirchner HL, Kimmel R et al. Significant variation in serotype-specific immunogenicity of the seven-valent Streptococcus pneumoniae capsular polysaccharide-CRM197 conjugate vaccine occurs despite vigorous T cell help induced by the carrier. J Infect Dis 2003; 187: 162938.
  • 15
    Kumboj KK, King CL, Greenspan NS et al. Immunization with Haemophilus influenzaType b-CRM197 conjugate vaccine elicits a mixed Th1 and Th2 CD4+T cell cytokine response that correlates with the isotype of antipolysaccharide antibody. J Infect Dis 2001; 184: 9315.
  • 16
    Wuorimaa T, Kayhty H, Eskola J et al. Activation of cell-mediated immunity following immunization with pneumococcal conjugate or polysaccharide vaccine. Scand J Immunol 2001; 53: 4228.
  • 17
    Hoshino Y, Morishima T, Kimura H et al. Antigen-driven expansion and contraction of CD8+-activated T cells in primary EBV infection. J Immunol 1999; 163: 573540.
  • 18
    McElhaney JE, Pinkoski M, Meneilly GS. Changes in CD45 isoform expression vary according to the duration of T-cell memory vaccination. Clin Lab Diagn 1995; 2: 7381.
  • 19
    Zepp F, Knuf M, Habermehl P et al. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun 1996; 64: 407884.
  • 20
    Eberl G, Brawand P, MacDonald HR. Selective bystander proliferation of memory CD4+ and CD8+T cells upon NK T cell or T cell activation. J Immunol 2000; 165: 430511.